Diagnostics
The on-ramp to the rest of the stack — at-home, in-clinic, and longitudinal diagnostics rewiring how women enter the system.
BrightHeart raises €11M Series A to scale AI prenatal ultrasound
AOA Dx reports 94.8% sensitivity for early-stage ovarian cancer in peer-reviewed publication
FDA draft guidance: sex-specific data in medical device trials
Signals in Diagnostics
- Funding ↗
- Research ↗Research · Oct 23AOA Dx reports 94.8% sensitivity for early-stage ovarian cancer in peer-reviewed publicationThe Index Editorial
- Ecosystem Shift ↗Ecosystem Shift · Oct 17Evvy surpasses 75,000 patients and 2,000 providers; launches at-home clinical care programThe Index Editorial
- Funding ↗Funding · May 20PHASE Scientific raises US$34M Series A for urine-based diagnostics (PHASIFY)The Index Editorial
- Policy ↗
Top organizations in Diagnostics
Evvy
StartupAt-home vaginal microbiome diagnostics and care pathways.
Weill Cornell Female Health Institute
Research InstituteResearch on diagnostics, hormonal aging, and chronic disease in women.
FemTech Focus
MediaIndustry media and conference covering women's health technology.
BillionToOne
StartupMolecular diagnostics for prenatal and family-planning testing.
BrightHeart
StartupAI-powered prenatal ultrasound for fetal cardiac defects.
Diamens
StartupMenstrual-blood-based endometriosis diagnostics.
Market maps · Diagnostics
Events · Diagnostics
Analysts covering Diagnostics
Regulatory · Diagnostics
- FDA: PCOS diagnostic criteriapending
- EU MDR: fertility device reclass.watch
Get the Diagnostics briefing weekly.
A focused read on what's moving in diagnostics — financings, research, regulatory shifts, and ecosystem moves.